Smith Mark A, Westerling-Bui Thomas, Wilcox Angela, Schwartz Julie
25913Charles River Laboratories, Reno, NV, USA.
Aiforia Inc, Cambridge, MA, USA.
Toxicol Pathol. 2021 Jun;49(4):905-911. doi: 10.1177/0192623320981560. Epub 2021 Jan 5.
Many compounds affect the cellularity of hematolymphoid organs including bone marrow. Toxicologic pathologists are tasked with their evaluation as part of safety studies. An artificial intelligence (AI) tool could provide diagnostic support for the pathologist. We looked at the ability of a deep-learning AI model to evaluate whole slide images of macaque sternebrae to identify and enumerate bone marrow hematopoietic cells. The AI model was trained and able to differentiate the hematopoietic cells from the other sternebrae tissues. We compared the model to severity scores in a study with decreased hematopoietic cellularity. The mean cells/mm from the model was lower for each increase in severity score. The AI model was trained by 1 pathologist, providing proof of concept that AI model generation can be fast and agile, without the need of a cross disciplinary team and significant effort. We see great potential for the role of AI-based bone marrow screening.
许多化合物会影响包括骨髓在内的血液淋巴器官的细胞构成。毒理病理学家的任务是在安全性研究中对它们进行评估。人工智能(AI)工具可为病理学家提供诊断支持。我们研究了一种深度学习AI模型评估猕猴胸骨全切片图像以识别和计数骨髓造血细胞的能力。该AI模型经过训练,能够将造血细胞与其他胸骨组织区分开来。在一项造血细胞减少的研究中,我们将该模型与严重程度评分进行了比较。随着严重程度评分的每一次增加,模型得出的平均每平方毫米细胞数会更低。该AI模型由1名病理学家进行训练,证明了AI模型生成可以快速灵活,无需跨学科团队且无需付出巨大努力。我们认为基于AI的骨髓筛查具有巨大潜力。